Search results
Results from the Health.Zone Content Network
rheumatoid arthritis. lupus. type 1 diabetes. thyroid disease. Crohn’s disease. certain allergies, with limited risk. asthma, with limited risk. Not all autoimmune systems present the same level ...
Summary. Person-to-person contact seems to be the main method of transmission of the novel coronavirus. Transmission typically occurs when: You breathe in respiratory droplets that contain the ...
Call 911, or get to a hospital’s emergency department as soon as possible if you develop any of the following symptoms: persistent or severe shortness of breath. persistent or severe chest or ...
t. e. The Access to COVID-19 Tools Accelerator (ACT Accelerator or ACT-A), or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. [1]
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019 (HCoV-19 or hCoV-19).
Loss of smell or taste. Nausea. Diarrhea. The virus can lead to pneumonia, respiratory failure, heart problems, liver problems, septic shock, and death. Many COVID-19 complications may be caused ...
Molnupiravir is safe and effective for people with mild to moderate COVID-19 who are at a higher risk of severe illness. Data shows it can lower your risk of death or hospitalization from a COVID ...
Previously, the CDC had urged people with COVID to stay home for at least five days. But the new instructions suggest staying home until at least 24 hours after a fever and symptoms have subsided.